Claritev (CTEV) Stock Price

Claritev Price

NYSE·CLOSED
23.36
​
Market closed

Revenue at Claritev has contracted by 1.1% per year over the past 7 years to 965.41 M USD. Earnings per share have grown at 20.0% per year over the last 3 years. For Claritev, the net margin of -29.4% is down versus 9.1% a few years ago. The consensus 12-month price target for Claritev is 38.00 USD, about 62.7% above where the stock trades today. Of 12 analysts, 10 rate the stock a buy — an overall Buy consensus.

Claritev stock price

Access this data via the Eulerpool API

Claritev business model & stock analysis

MultiPlan Corp. provides healthcare cost management solutions. The company is headquartered in New York City, New York and currently employs 2,500 full-time employees. The company went IPO on 2020-02-10. Its Analytics-Based Services is a suite of data-driven algorithms and insights that detect claims over-charges and either negotiate or recommend fair reimbursement for out-of-network medical costs using a variety of data sources and pricing algorithms. Its Network-Based Services contracts discounts with healthcare providers to form an independent preferred provider organizations (PPO), as well as outsourced network development and/or management services. Its Payment and Revenue Integrity Services provides data, technology and clinical solutions deployed to identify and remove improper and unnecessary charges before or after claims are paid, or to identify and help restore and preserve underpaid premium dollars. Its Software as a Service (SaaS) platform ingests, validates, and stores data and applies advanced descriptive, predictive and prescriptive analytics.

Frequently asked questions about Claritev

Analysts currently set an average price target of 42.40 USD for the Claritev stock (median: 38.00 USD), implying +81.5 % versus the latest price. The consensus is based on 12 analyst ratings.

12 analysts currently rate the Claritev stock: 10 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Claritev to generate revenue of 1.01 B USD and earnings per share of -15.12 USD.

Converted at the current exchange rate, the Claritev share trades at 20.76 EUR (23.36 USD).

The Claritev share (CTEV) is listed on 1 stock exchanges, including: NYSE (MPLN).

The expected revenue of Claritev is 1.01 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Claritev is -248.44 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Claritev is currently -1.55. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Claritev stock.

The price-to-sales ratio (P/S) of Claritev is currently 0.38. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Claritev stock.

The Eulerpool Quality Score for Claritev is 1/10.

The ISIN of Claritev is US62548M2098. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Claritev is CTEV. The ticker symbol is used to trade Claritev shares on the stock exchange.

Fair ValueTerminal
21.72 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
321,804.33 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website multiplan.us
Currency
USD
Initial public offering
Feb 10, 2020
ISIN
US62548M2098
Cusip
62548M100
Market capitalization
383.92 M USDSmall Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
0.17
P/E ratio
P/Ee 2026
-1.55
P/Ee 2027
-1.73
P/Ee 2028
-1.97
P/S
P/Se
0.38
EV/EBIT
109.76
P/B Ratio
4.57
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-6.43 %
Gross Margin
27.61 %
EBIT Margin
4.67 %
Net Margin
-29.45 %
EPS (Earnings Per Share)
-17.30 USD
Net Debt / EBIT
101.24
Debt/Equity
-26.42
Last updated Oct 5, 2026, 6:24 PM

Claritev Peer Group

Claritev Ticker

NEW YORK · MPLN

All fundamentals and in-depth analysis of Claritev

Our stock analysis for Claritev stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Claritev. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.